Hemophagocytic lymphohistiocytosis: Recent progress in the pathogenesis, diagnosis and treatment

Figure 2 Flow chart illustrates the treatment pathways in hemophagocytic lymphohistiocytosis. Hematopoietic stem cell transplantation (HSCT) is required for the majority of primary hemophagocytic lymphohistiocytosis (HLH) and some of LAHS and EBV-HLH. FHL: Familial hemophagocytic lymphohistiocytosis; MAS: Macrophage activation syndrome; LAHS: Lymphoma-associated HLH; SCE: Steroids + cyclosporine A + etoposide; SCA: Steroids + cyclosporine A + ATG; IVIG: Intravenous immune globulin; S/C: Steroids alone or cyclosporine A alone or two drug combination.